Tibet Duo Rui Pharmaceutical
301075
Alnera Aluminium
301613
ChengDu Sheng Nuo Biotec
688117
4
THEC
833509
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
000026 FIYTA Precision Technology
- 11.03
- -0.02-0.18%
Trading Mar 31 09:57 CST
4.48BMarket Cap20.31P/E (TTM)
11.10High10.90Low12.62KlotVolume11.00Open11.05Pre Close13.88MTurnover0.35%Turnover Ratio20.31P/E (Static)405.76MShares11.7852wk High1.32P/B4.02BFloat Cap8.5252wk Low12.16Limit Up364.52MShs Float25.24Historical High9.95Limit Down1.81%Amplitude-1.38Historical Low0.40Dividend TTM11.00Avg Price5.31KlotAsk3.63%Div YieldTTM100Lot Size6.62KlotBid
FIYTA Precision Technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -13.77%3.94B | -13.82%3.04B | -12.18%2.08B | -11.24%1.07B | 4.95%4.57B | 4.19%3.53B | 8.29%2.36B | 2.25%1.2B | -16.97%4.35B | -17.12%3.39B |
| Operating revenue | -13.77%3.94B | -13.82%3.04B | -12.18%2.08B | -11.24%1.07B | 4.95%4.57B | 4.19%3.53B | 8.29%2.36B | 2.25%1.2B | -16.97%4.35B | -17.12%3.39B |
| Other operating revenue | -26.89%11.69M | ---- | -24.46%5.88M | ---- | -8.72%15.98M | ---- | 15.90%7.79M | ---- | -7.34%17.51M | ---- |
| Total operating cost | -12.11%3.65B | -12.67%2.79B | -11.11%1.89B | -8.94%974.43M | 3.68%4.15B | 2.69%3.19B | 5.46%2.13B | 0.44%1.07B | -15.32%4B | -14.93%3.11B |
| Operating cost | -14.77%2.48B | -15.35%1.91B | -13.75%1.3B | -11.68%678.09M | 6.08%2.91B | 5.53%2.26B | 10.11%1.51B | 5.85%767.72M | -16.64%2.74B | -16.14%2.14B |
| Operating tax surcharges | -13.03%31.48M | -18.54%20.65M | -22.22%12.26M | -9.93%6.38M | 17.51%36.19M | 11.77%25.35M | 10.99%15.76M | 7.01%7.09M | -18.01%30.8M | -12.87%22.68M |
| Operating expense | -4.46%882.78M | -2.52%673.76M | -1.42%449.79M | -1.09%225.63M | -0.84%924.01M | -3.71%691.2M | -4.51%456.27M | -11.39%228.11M | -11.25%931.83M | -12.80%717.8M |
| Administration expense | -10.75%183.28M | -20.36%127.78M | -14.73%89.21M | -5.29%45.47M | -6.23%205.36M | -8.61%160.45M | -10.36%104.62M | -13.34%48.01M | -16.29%219.01M | -7.32%175.56M |
| Financial expense | -16.51%17.92M | -16.20%14.17M | -21.05%9.62M | -26.07%4.43M | 1.33%21.47M | -10.97%16.9M | 2.62%12.19M | -22.38%5.99M | -38.90%21.19M | -30.83%18.99M |
| -Interest expense (Financial expense) | -16.58%10.7M | -16.17%8.08M | -22.74%5.17M | -16.31%2.5M | -23.88%12.82M | -33.47%9.64M | -31.24%6.69M | -42.31%2.99M | -27.26%16.85M | -21.88%14.49M |
| -Interest Income (Financial expense) | 13.93%-4.93M | 17.24%-3.42M | 10.14%-2.19M | -16.98%-1.02M | -45.84%-5.72M | -36.81%-4.13M | -22.72%-2.43M | -16.27%-873.02K | -9.31%-3.92M | -3.90%-3.02M |
| Research and development | -3.12%56M | -1.28%42.79M | -2.26%27.53M | 9.56%14.44M | -5.38%57.8M | 17.75%43.34M | 12.53%28.16M | 1.47%13.18M | 5.68%61.09M | -8.31%36.81M |
| Credit Impairment Loss | -96.10%266.49K | -66.65%1.56M | -37.13%2.72M | 1,340.37%2.98M | 40.91%6.83M | 1,103.05%4.69M | 234,313.16%4.33M | -901.60%-240.19K | 143.75%4.85M | 137.46%389.47K |
| Asset Impairment Loss | -3,472.47%-19.29M | --28.34K | --28.34K | ---- | 101.52%571.98K | ---- | ---- | ---- | -45.49%-37.63M | 70.98%-348.22K |
| Other net revenue | -170.02%-9.59M | -32.19%8.16M | -1.89%9.08M | 205.35%7.67M | 224.40%13.7M | -30.42%12.03M | -36.94%9.25M | -30.62%2.51M | 0.98%-11.01M | 12.49%17.29M |
| Invest income | 92.59%-431.25K | 129.22%495.97K | 118.49%313.83K | ---- | -292.29%-5.82M | -168.93%-1.7M | -168.93%-1.7M | ---- | -19.40%3.03M | 51.14%2.46M |
| -Including: Investment income associates | 83.58%-955.57K | 105.29%89.87K | 105.29%89.87K | ---- | -292.29%-5.82M | -168.93%-1.7M | -168.93%-1.7M | ---- | -19.40%3.03M | 51.14%2.46M |
| Asset deal income | 245.23%2.37M | 197.28%2.65M | 3,889.57%2.91M | 4,111.24%2.95M | 646.12%685.87K | 179.49%892.42K | 90.60%-76.69K | 89.92%-73.52K | -87.41%91.93K | -521.30%-1.12M |
| Other revenue | -34.48%7.49M | -58.06%3.42M | -53.62%3.1M | -38.39%1.74M | -38.68%11.44M | -48.77%8.15M | -49.95%6.69M | -34.60%2.83M | -12.57%18.65M | -1.56%15.91M |
| Operating profit | -34.59%283.28M | -25.14%258.7M | -21.14%192.58M | -25.75%98.39M | 27.31%433.09M | 18.09%345.56M | 36.48%244.22M | 18.46%132.51M | -32.69%340.19M | -34.13%292.63M |
| Add:Non operating Income | -24.04%3.62M | 144.94%1.63M | 131.03%1.38M | -29.18%340.41K | 270.61%4.77M | 145.24%663.76K | 185.98%596.52K | 555.57%480.65K | 105.15%1.29M | 7.23%270.66K |
| Less:Non operating expense | -8.24%788.92K | -34.12%429.28K | -4.38%278.83K | -90.80%20.36K | -63.43%859.77K | -14.83%651.66K | -64.69%291.6K | -71.24%221.41K | -36.21%2.35M | -40.99%765.16K |
| Total profit | -34.53%286.12M | -24.79%259.89M | -20.79%193.68M | -25.66%98.71M | 28.86%437M | 18.29%345.57M | 37.12%244.53M | 19.43%132.77M | -32.49%339.12M | -34.09%292.14M |
| Less:Income tax cost | -36.66%65.77M | -22.18%62.27M | -18.53%46.55M | -21.55%23.21M | 43.33%103.83M | 28.36%80.02M | 51.79%57.13M | 19.21%29.58M | -36.72%72.44M | -38.06%62.34M |
| Net profit | -33.86%220.35M | -25.58%197.62M | -21.48%147.14M | -26.83%75.5M | 24.93%333.18M | 15.56%265.56M | 33.19%187.4M | 19.50%103.19M | -31.24%266.68M | -32.92%229.8M |
| Net profit from continuing operation | -33.86%220.35M | -25.58%197.62M | -21.48%147.14M | -26.83%75.5M | 24.93%333.18M | 15.56%265.56M | 33.19%187.4M | 19.50%103.19M | -31.24%266.68M | -32.92%229.8M |
| Net profit of parent company owners | -33.86%220.35M | -25.58%197.62M | -21.48%147.14M | -26.83%75.5M | 24.93%333.18M | 15.56%265.56M | 33.19%187.4M | 19.50%103.19M | -31.24%266.68M | -32.92%229.8M |
| Earning per share | ||||||||||
| Basic earning per share | -33.37%0.5385 | -25.08%0.4824 | -21.01%0.3568 | -27.03%0.1828 | 26.32%0.8082 | 16.56%0.6439 | 34.80%0.4517 | 20.26%0.2505 | -29.19%0.6398 | -30.91%0.5524 |
| Diluted earning per share | -33.40%0.5378 | -25.17%0.4818 | -21.10%0.3564 | -27.15%0.1825 | 26.21%0.8075 | 16.56%0.6439 | 34.80%0.4517 | 20.26%0.2505 | -29.19%0.6398 | -30.91%0.5524 |
| Other composite income | -126.78%-3.64M | -116.56%-1.29M | -159.30%-5.58M | -159.72%-6.46M | 1.40%13.59M | 27.93%7.79M | 2,113.69%9.41M | -5,026.54%-2.49M | 255.15%13.4M | 177.34%6.09M |
| Other composite income of parent company owners | -126.78%-3.64M | -116.56%-1.29M | -159.30%-5.58M | -159.72%-6.46M | 1.40%13.59M | 27.93%7.79M | 2,113.69%9.41M | -5,026.54%-2.49M | 255.15%13.4M | 177.66%6.09M |
| Total composite income | -37.50%216.71M | -28.18%196.33M | -28.07%141.56M | -31.45%69.03M | 23.81%346.76M | 15.88%273.35M | 39.46%196.8M | 16.68%100.7M | -26.14%280.08M | -29.53%235.89M |
| Total composite income of parent company owners | -37.50%216.71M | -28.18%196.33M | -28.07%141.56M | -31.45%69.03M | 23.81%346.76M | 15.88%273.35M | 39.46%196.8M | 16.68%100.7M | -26.14%280.08M | -29.53%235.89M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.